Chaperones (e.g., HSPA1A, HSPB6, DNAJC6, DNAJA2, and DNAJA4) have been shown to be upregulated in AD animal models as a neuroprotective mechanism inhibiting the aggregation of tau and Aβ fibril formation [35,36,37]. The gene discussed is MAPT; the disease is Alzheimer disease.